Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

Metastatic Anaplastic Carcinoma of the Small Intestine Arising from The Lung

Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK, Juhng SW

  • Cancer Res Treat.
  • 2003 Aug;35(4):364-366.
A metastatic carcinoma of the small intestine is rare. Here, the case study of an 80-year-old lung carcinoma patient, with generalized peritonitis due to neoplastic perforation of the small intestine...
The Expressions of Cytokeratin 7 and 20 in Epithelial Tumors: A Survey of 91 Cases

Kim DH, Joo JE, Kim EK, Lee HJ, Lee WM

  • Cancer Res Treat.
  • 2003 Aug;35(4):355-363.
PURPOSE: This study was performed to determine the expressions of cytokeratin 7 and cytokeratin 20 in epithelial neoplasms, and to investigate their potential role in the differential diagnosis of carcinomas...
Clinical Value of Whole Body F-18 FDG PET in The Management of Recurrent Colorectal Malignancy

Lim SB, Choi HS, Kang SB, Heo SC, Park YJ, Jeong SY, Park KJ, Yang HK, Hwang KH, Jeong JM, Lee DS, Chung JK, Lee MC, Kang KW, Park JG

  • Cancer Res Treat.
  • 2003 Aug;35(4):349-354.
PURPOSE: The aim of this study was to evaluate the clinical value of whole body 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in the patient with a recurrence of a previously treated...
TRAIL-Mediated Apoptosis in Human Liver Chang Cells

Park C, Hong SW, Jin SH, Kim NS, Cho KH, Cheon JH, Ahn JY, Yang JK, Park R

  • Cancer Res Treat.
  • 2003 Aug;35(4):341-348.
PURPOSE: Tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL)/APO-2L is a member of the TNF family that can kill a wide variety of tumor cells, but not normal cells. This...
Clinical Significance of the Levels of Serum Cholesterol in Patients with Gastric Cancer

Kim TH, Ahn SJ, Jung WT, Lee OJ, Ha WS, Jang JS

  • Cancer Res Treat.
  • 2003 Aug;35(4):335-340.
PURPOSE: The relationship between serum cholesterol levels and mortality is complex. Serum cholesterol levels correlate positively with coronary artery disease, but some studies have suggested a negative relationship in cancer...
Concurrent FP (5-fluorouracil, cisplatin) Chemoradiotherapy for Patients with Esophageal Cancer

Kim MO, Hong ES, Chai JY, Leem JM, You IY, Kim WD, Park WY, Kim ST, Lee KH

  • Cancer Res Treat.
  • 2003 Aug;35(4):330-334.
PURPOSE: The outcomes of a surgical approach for patients with an esophageal carcinoma remain unsatisfactory despite its high complication rates. We conducted a phase II trial, using combined FP (5-fluorouracil...
Prognostic Significance of KAI-1 and Survivin Expressions in Ovarian Epithelial Carcinomas

Lee JH, Lee SM, Choi JS

  • Cancer Res Treat.
  • 2003 Aug;35(4):323-329.
PURPOSE: The purpose of this study was to evaluate the expressions of KAI-1 and survivin, and to investigate their correlation with the clinical stage and survival rate of patients with...
Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer

Lee C, Kim SJ, Na JY, Park CS, Lee SY, Kim IH, Oh YK

  • Cancer Res Treat.
  • 2003 Aug;35(4):314-322.
PURPOSE: The biallelic expression of insulin-like growth factor-II (IGF2) and H19 has been reported to be associated with the progression of several tumors. Here, the promoter usage and expression levels...
New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology

Kim YW, Suh MJ, Bae JS, Bae SM, Yoon JH, Hur SY, Kim JH, Ro DY, Lee JM, Namkoong S, Kim CK, Ahn WS

  • Cancer Res Treat.
  • 2003 Aug;35(4):304-313.
No abstract available.
Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Kang HJ, Kim MK, Kim YG, Lee JL, Lee KH, Hyun MS, Bae SH, Ryoo HM

  • Cancer Res Treat.
  • 2003 Aug;35(4):299-303.
PURPOSE: This study was conducted to evaluate the efficacy and safety of combination chemotherapy, with docetaxel and cisplatin, as a first line treatment for advanced non-small cell lung cancer. MATERIALS AND...
Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

Kim YJ, Sohn JH, Kim C, Kim YT, Kim HJ, Ahn JB, Kim SK, Chang J, Yoo NC, Kim JH, Cho JY

  • Cancer Res Treat.
  • 2003 Aug;35(4):294-298.
PURPOSE: With the increased use of chemotherapy for non small cell lung cancer (NSCLC), a growing group of patients can now be considered for second-line chemotherapy. However, guidelines for the...
Microsatellite Alterations in Serum DNA of Lung Cancer Patients

Oh SC, Yoo YD, Yoon SY, Kim SJ, Seo JH, Kim KT, Shin SW, Kim YH, Kim YH, Kim JS

  • Cancer Res Treat.
  • 2003 Aug;35(4):289-293.
No abstract available.
Advances in Nuclear Oncology

Kim EE

  • Cancer Res Treat.
  • 2003 Aug;35(4):281-288.
No abstract available.
Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future

Park K

  • Cancer Res Treat.
  • 2003 Aug;35(4):279-280.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr